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The extent to which self-assessed work ability collected during treatment can predict return-to-work in cancer patients is unknown.
In this prospective study, we consecutively included employed cancer patients who underwent treatment with curative intent at 6
months following the first day of sick leave. Work ability data (scores 0–10), clinical and sociodemographic data were collected at 6
months, while return-to-work was measured at 6, 12 and 18 months. Most of the 195 patients had been diagnosed with breast
cancer (26%), cancer of the female genitals (22%) or genitourological cancer (22%). Mean current work ability scores improved
significantly over time from 4.6 at 6 months to 6.3 and 6.7 at 12 and 18 months, respectively. Patients with haematological cancers
and those who received chemotherapy showed the lowest work ability scores, while patients with cancer of urogenital tract or with
gastrointestinal cancer had the highest scores. Work ability at 6 months strongly predicted return-to-work at 18 months, after
correction for the influence of age and treatment (hazard ratio¼1.37, CI 1.27–1.48). We conclude that self-assessed work ability is
an important factor in the return-to-work process of cancer patients independent of age and clinical factors.
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Cancer diagnoses in individuals who are still at the working age are
becoming more common, with almost half of the adult cancer
survivors being younger than 65 years (Short et al, 2005). With the
sustained improvement in treatment and prognosis of many forms
of cancer, an increasing number of survivors of cancer return-to-
work following treatment or continue to work during therapy
(Hoffman, 2005).
Returning to work is important for both cancer patients
themselves and the society. Patients often regard returning to
work as a symbol of complete recovery (Spelten et al, 2002) and
regaining a normal life (Kennedy et al, 2007), while from the
viewpoint of the society, it is an economic and social imperative to
encourage patients to return-to-work whenever possible.
Despite its importance, the impact of cancer and its treatment
on work (dis)continuation or resumption has not been studied
frequently (Steiner et al, 2004). However, a number of studies have
documented the impact of cancer on employment and they
reported that approximately 60% of the cancer patients return to
work within 1–2 years (Spelten et al, 2002; Maunsell et al, 2004;
Bradley et al, 2005; Nieuwenhuijsen et al, 2006). The return-to-
work in cancer survivors seems, therefore, to be problematic in
some patients but certainly not in all. Hence, it is important to
identify those patients with a higher risk of lasting absence from
work and to provide them with the appropriate support and
counselling in returning to work.
To examine the factors that would influence this return-to-work
process, we previously studied a model based on the assumption
that cancer-related symptoms would mediate return-to-work
(Spelten et al, 2003). However, results showed that diagnosis and
treatment were much stronger predictors of return-to-work than
cancer-related symptoms such as fatigue, depressive symptoms or
cognitive problems. In addition, recent empirical studies have
indicated the importance of patients’ expectations of recovery as
good predictors of return-to-work and rehabilitation independent
of diagnosis and treatment (Ekbladh et al, 2004; Verbeek, 2006).
Studies in other disorders have also shown that a patient’s own
assessment of work ability (Reiso et al, 2003), expectation of job
success (Ekbladh et al, 2004) and work recovery expectations
(Hogg-Johnson and Cole, 2003; Nieuwenhuijsen et al, 2006; Turner
et al, 2006) do predict return-to-work.
A theory that could explain these mechanisms is the well-known
Leventhal’s ‘model of illness representations’, which states that
people’s cognitive representations of illness exert an important
influence on their strategies for coping, which in turn influence
illness outcomes (Leventhal et al, 1984). It has been shown in other
diseases such as multiple sclerosis, rheumatoid arthritis and
kidney disease (Vaughan et al, 2003; Carlisle et al, 2005;
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sFowler and Baas, 2006) that, on the basis of this model, the
functional outcome might be worse or better, irrespective of
the objective medical seriousness of the illness. This strongly
suggests that the ideas a cancer patient has about the disabilities
that might result from the diagnosis and treatment will encourage
or hinder his or her return-to-work.
With these new insights, our data were reanalysed with the focus
on the patients’ assessments of work ability as predictor of return-
to-work. In our earlier publication on return-to-work of cancer
survivors, we did not use information on the self-assessed ability
to work because at the time it was outside the focus of our study
(Spelten et al, 2003).
The aim of the current study is therefore (1) to examine any
change in work ability scores in cancer patients over time and to
study differences among patient groups and (2) to assess the extent
to which self-assessed work ability predicts return-to-work among
cancer survivors independent of diagnosis, treatment and cancer-
related symptoms.
MATERIALS AND METHODS
Patients
Eligible patients had to be between 18 and 58 years to have a
primary diagnosis of cancer, to be in paid employment at the time
of diagnosis, to be within 4–6 months following their first day of
sick leave, and to have had treatment with curative intent. They
were consecutively recruited in three hospitals in The Netherlands
where the attending physician obtained the patients’ informed
consent. The study has been carried out with the approval of the
hospitals’ medical ethical committees.
Questionnaires were distributed three times to the patients, at
entry into the cohort and 6 and 12 months later, to obtain
information on their return-to-work, diagnosis, treatment, work
ability and cancer-related symptoms. Details of the design and
material of this prospective cohort study have been reported
earlier (Spelten et al, 2003). The data were collected between 1998
and 2002. For the current study, data on return-to-work and work
ability were collected at study entry and 6 and 12 months later.
Data on work load, work stress, cancer-related factors and
sociodemographic factors had been collected at baseline. All
questionnaires were mailed to the patients’ homes.
Measures
Return-to-work Data on return-to-work were measured on the
basis of two measures: time to return-to-work after sick leave and
rate of return-to-work at a specific point in time. All patients in
The Netherlands typically have access to sick leave. Time to return-
to-work at 18 months after the first day of sick leave was calculated
as the number of days between the first date of sick leave and the
first day the patient returned to work. Any kind of work
resumption qualified as a return-to-work, irrespective of the
number of hours that the patients worked prior to their diagnosis.
In addition, patients were asked to indicate if they were still on sick
leave (yes/no) at 6, 12 and 18 months following their first day of
sick leave.
Work ability, work load and work stress Current work ability was
measured with the first three items from the Work Ability Index
(WAI) (Ilmarinen and Tuomi, 1993, p 142; Tuomi et al, 1998),
which is a reliable and valid measure of work ability (Ilmarinen
and Tuomi, 1993, p 142; de Zwart et al, 2002). First, current work
ability was assessed by asking the patients to estimate their current
work ability compared with their lifetime best (0¼cannot work at
all to 10¼best ever). In addition, we asked the cancer patients to
rate both their current physical and mental work ability in relation
to job demands (0¼very low to 5¼very high).
Physical workload was measured with a seven-item scale and
work stress with an 11-item scale from the Dutch Questionnaire on
Experience and Judgement of Work (VBBA) (van Veldhoven et al,
2002). Patients were asked to assess their levels of workload and
work stress for the work situation prior to diagnosis. The scores
range from 0 to 100, with higher scores indicating a higher level of
physical work and more work stress, respectively.
Cancer-related and sociodemographic factors Information about
diagnosis and treatment was reported by the patients. Twenty-two
different diagnoses were then grouped according to cancer
site into (1) breast cancer, (2) haematological oncology, (3)
gastrointestinal cancer, (4) cancer of the female genitals,
(5) genitourological cancer and (6) other types of cancer.
Treatments were classified into three categories: (1) surgery, (2)
radiotherapy or radiotherapy plus surgery and (3) chemotherapy
or chemotherapy plus radiotherapy and/or surgery.
We measured cancer-related complaints with validated ques-
tionnaires and converted all scores to a scale ranging from 0 to
100, with higher scores indicating more complaints (Spelten et al,
2003). The following complaints were measured: physical cancer-
related complaints (de Haes et al, 1990), general fatigue (Smets
et al, 1995), sleep quality (Buysse et al, 1989), depressive
symptoms (Radloff, 1977), psychological distress (de Haes et al,
1990), cognitive dysfunction (Broadbent et al, 1982) and global
quality of life (de Haes et al, 1990).
Further information was enquired concerning marital status
(single, married, cohabitating or other), having children in the
household, age, gender, education (lower education, high school,
college/university) and work hours per week before the diagnosis
of cancer.
Statistical analysis
The work ability scores measured at 6, 12 and 18 months after the
first day of sick leave were analysed with the mixed-model
procedure based on repeated measurements to examine any
change in work ability scores over time. We also used the mixed-
model procedure to analyse any differences over time in work
ability scores between several patient groups: age groups (18–27,
28–37, 38–47 and 48–58 years), education groups, men and
women, diagnosis groups and treatment groups. Time, group and
time*group interaction effects were considered fixed effects and an
autoregressive covariance structure was selected because of
correlated work ability scores over time. In case of a statistically
significant main effect, post hoc analyses were performed between
time points and between groups with pairwise comparisons based
on the use of the mean difference of the estimated marginal means.
To examine whether self-assessed work ability can predict
return-to-work in cancer patients a year later, taking the impact of
clinical-, work- and subject-related factors into account, we used a
two-step procedure. First, univariate analyses using Kaplan–Meier
analyses were performed for the relationship between time taken
to return-to-work (in days) at 18 months and each of the predictive
factors measured at baseline (on average 6 months after the first
day of sick leave): current work ability, mental work ability,
physical work ability, physical work load, work stress, physical
complaints, fatigue, sleep impairments, depression, psychological
distress, cognitive dysfunction, age, gender, education and the
clinical factors (diagnosis and treatment type). Next, we analysed
the impact of work ability in addition to personal and clinical
factors in a multivariate Cox regression analysis. We entered all
variables for which the log-rank test returned a P-valuep0.10 into
a Cox regression analysis with forward selection of variables. With
this method, the best predictors of future return-to-work are
selected (Altman, 1991). Because it was possible for patients to
return to work before our first measurement at 6 months, we
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srepeated both analyses with the exclusion of patients who had
returned before 6 months. Since this is a survival analysis, hazard
ratios (HRs) usually indicate the risk of dying, while in our case the
event is returning to work. Therefore, an HR higher than one
indicates the higher ‘risk’ of return-to-work.
Alpha was set at 0.05 unless stated otherwise and all tests were
two-sided. Analyses were conducted with SPSS 13.
RESULTS
The first questionnaire was completed by 235 of the 264 eligible
patients (a response of 89%), while a total of 29 patients declined
participation in this study. The second questionnaire at 6 months
follow-up was completed by 221 of the 235 participating patients
(a follow-up response of 94%). At 12 months of follow-up, the
questionnaire was returned by 195 patients (an 83% follow-up
response and 74% of the initially eligible patients), while 25
patients refused to return the questionnaire, 13 patients had died
and 2 questionnaires got lost in the mail.
Table 1 shows sociodemographic and cancer-related characteris-
tics at 6 months after the first day of sick leave. Half of the patients
had either breast cancer (26%) or cancer of the female genitals
(22%), while another 22% of the patients had been diagnosed with
genitourological cancer. Before diagnosis and treatment, patients
worked an average of 34h per week, and 6 months after the
diagnosis, 46 patients (24%) had already returned to work or had
continued working. Data on work hours per week, children,
fatigue, depression, sleep problems, physical complaints, cognitive
dysfunction, psychological distress, work load and work stress
have been reported previously (Spelten et al, 2003).
Table 2 depicts the mean values of current work ability at 6, 12
and 18 months after the first day of sick leave; the values improved
significantly over time (Po0.001) from 4.6 at 6 months to 6.3 at 12
months and to 6.7 at 18 months. Post hoc analyses of work ability
scores showed that all three time points were significantly different
from each other (Po0.001 to P¼0.035). All age groups improved
over time (Po0.001) with the 28- to 37-year-old patients
increasing most from 4.8 to 7.5. No differences in work ability
scores were, however, found between age groups (P¼0.12). Work
ability scores of both men and women improved over time
(Po0.001), but women improved more (P¼0.002). Male patients
showed higher work ability scores at 6 months (5.8 vs 3.8,
Po0.0001), but not at 12 months (6.8 vs 6.0, P¼0.053) or at 18
months (6.9 vs 6.7, P¼0.52). Higher educated patients seemed to
have higher work ability scores, but the differences were not
statistically significant (P¼0.13). With regard to diagnosis, we
found significant differences between the different diagnosis
groups (Po0.001). The haematological oncology patients showed
the significantly (Po0.001) lowest scores of 3.3, 4.5 and 5.0 at 6, 12
and 18 months, respectively. The patients with genitourological
cancer had the highest scores of 6.9 and 7.8 at 6 and 12 months
(Po0.001), and the patients with gastrointestinal cancer scored the
highest work ability of 7.6 at 18 months (Po0.001). Patients with
cancer of the female genitals and breast cancer patients improved
most over time (P¼0.01).
Figure 1 shows the work ability scores for the three treatment
combinations: (1) surgery; (2) chemotherapy or chemotherapy
plus radiotherapy and/or surgery; and (3) radiotherapy or
radiotherapy plus surgery, over time. Analyses revealed that scores
improved over time for all three groups and that the group of
patients that received chemotherapy or chemotherapy plus radio-
therapy and/or surgery consistently showed lower work ability
scores than the group that received surgery or radiotherapy (plus
surgery) (Po0.001). Improvement was not statistically different in
the three groups (P¼0.45).
At 6 months after diagnosis, 24% of patients had returned to
work, at 12 months 50%, and at 18 months 64% had returned.
Results of univariate analyses using the Kaplan–Meier analyses
showed that the time taken to return-to-work measured at 18
months was related to the following factors measured at 6 months:
Table 1 Sociodemographic and cancer-related characteristics at base-
line, on average 6 months after the first day of sick leave
N¼195 patients n (%)
Age (mean (s.d.)) 42.2 (9.3)
Sex (male) 78 (40%)
Returned-to-work 46 (24%)
Education
Lower 52 (27%)
High school 83 (42%)
College/university 60 (31%)
Marital status
Single 24 (12%)
Married/cohabiting 160 (82%)
Divorced 8 (4%)
Widower 3 (2%)
Diagnosis
Breast cancer 51 (26%)
Haematological oncology 24 (12%)
Gastrointestinal cancer 23 (12%)
Cancer of the female genitals 43 (22%)
Genitourological cancer 43 (22%)
Other 11 (6%)
Treatment
Surgery 41 (21%)
Chemotherapy or chemotherapy plus radiotherapy and/or surgery 88 (45%)
Radiotherapy or radiotherapy plus surgery 66 (34%)
Table 2 Mean value of current work ability according to socio-
demographic and disease-related factors at 6, 12 and 18 months after
the first day of sick leave
Workability score
a (mean (s.d.))
N¼195 patients 6 months 12 months 18 months
All patients
b 4.59 (3.2) 6.31 (2.7) 6.74 (2.7)
Age
18–27 years 5.33 (3.6) 5.71 (3.9) 7.27 (2.9)
28–37 years 4.81 (3.4) 6.80 (2.5) 7.51 (2.4)
38–47 years 4.53 (3.2) 6.65 (2.3) 6.80 (2.3)
48–58 years 4.31 (3.0) 5.73 (2.8) 5.97 (3.1)
Sex
c
Male 5.76 (3.0) 6.78 (2.6) 6.91 (2.8)
Female 3.83 (3.1) 6.00 (2.7) 6.65 (2.6)
Education
Lower 3.90 (3.3) 6.14 (3.0) 6.26 (3.2)
High school 4.51 (3.0) 6.31 (2.6) 6.77 (2.5)
College/university 5.33 (3.4) 6.46 (2.6) 7.15 (2.6)
Diagnosis
c
Breast cancer 3.59 (3.1) 5.90 (2.3) 6.49 (2.5)
Haematological oncology 3.29 (3.0) 4.46 (3.4) 4.95 (3.6)
Gastrointestinal cancer 5.52 (2.7) 6.95 (2.1) 7.57 (1.6)
Cancer of the female genitals 3.91 (3.1) 6.29 (2.9) 7.00 (2.6)
Genitourological cancer 6.86 (2.5) 7.79 (1.7) 7.33 (2.7)
Other 4.09 (3.4) 5.36 (2.9) 6.55 (2.5)
aRange 0–10; 10 indicating best work ability ever.
bWork ability score change over
time: Po0.01.
cDifference between groups: Po0.01.
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quality of life, fatigue, physical complaints, cognitive functioning,
age, physical work load, work stress, gender, diagnosis and
treatment (at the Pp0.10 level). Sleep impairments, depression,
psychological distress and education did not significantly predict
return-to-work. Results of the analysis without the 46 patients who
had already returned to work at 6 months showed the same factors
except for gender, which did not significantly predict return-to-
work.
The factors that were predictive for return-to-work at 18 months
were entered in the Cox regression with a forward selection to
identify the strongest predictors of return-to-work. Results in
Table 3 show that in the final model, age, current work ability and
treatment are still significant. Current work ability, physical work
ability and mental work ability were highly correlated and,
therefore, only current work ability remained in the model.
Likewise, treatment and diagnosis were highly correlated, and only
treatment was selected for the final model. Patients treated with
surgery alone had the highest chance of returning to work quickly.
Those who were treated with radiotherapy or radiotherapy plus
surgery had an HR of 0.63 (95% CI: 0.39–1.0), corrected for age
and work ability, of returning to work and were thus 1.6 times
more likely to stay off work than patients with surgery alone.
Patients treated with chemotherapy, either alone or in combination
with other treatment modalities, had an HR of 0.41 (95% CI:
0.25–0.69) and their risk of staying off work was therefore 2.4
times higher than patients treated with surgery alone, corrected for
age and work ability. For current work ability itself, every 1 point
increase on the 11-point scale meant a 1.37 higher chance of
returning to work earlier, after correction for the influence of age
and treatment. Figure 2 shows the plot of the work ability scores in
relation to return-to-work after adjustment for age and treatment.
The plot shows that of the patients with the lowest work ability
scores (0–5) at 6 months after the first day of sick leave, the
majority (55–80%) did not return to work in the first year after
diagnosis. Patients with very high work ability scores (8, 9, 10) did
usually return to work within half a year, while virtually all of these
high-scoring patients were back at work after the first year.
Results of the analysis without the 46 patients who had already
returned to work at 6 months showed that in this model the
strongest predictors of return-to-work were not only work ability
(HR¼1.23; CI, 1.12–1.36), treatment (chemotherapy HR¼0.33;
CI, 0.18–0.60; radiotherapy HR¼0.52; CI, 0.29–0.95) and age
(HR¼0.67; CI, 0.53–0.86) but also mental work ability (HR¼1.41;
CI, 1.05–1.89) and cognitive dysfunction (HR¼1.03; CI,
1.01–1.05).
DISCUSSION
The aim of our study was to examine changes in work ability
scores in cancer patients over time and to study differences
between patient groups and, furthermore, to assess the extent to
which self-assessed work ability predicts return-to-work among
cancer survivors independent of diagnosis, treatment and cancer-
related symptoms.
We found that the cancer patients’ work ability scores at 6, 12
and 18 months after the first day of sick leave improved
significantly over time. Men scored higher on work ability than
women but no differences were found between age or education
groups. Furthermore, the haematological oncology patients and
the patients who received chemotherapy or chemotherapy plus
radiotherapy and/or surgery consistently showed lower work
ability scores. Finally, self-assessed work ability 6 months after
the first day of sick leave proved to be a strong predictor of later
return-to-work in cancer survivors independent of age and
therapy.
This is the first longitudinal study in which the impact of work
ability on return-to-work has been established in a systematic way.
The cohort has been followed for a considerable amount of time,
the number of patients lost to follow up was relatively small and all
factors have been measured with validated instruments.
Table 3 Cox regression analysis on return to work
Time to return to work
N¼195 Hazard ratio 95% CI
Age, 10-year categories 0.78 0.65–0.94
Current work ability 1.37 1.27–1.48
Treatment
Surgery (reference) 1.00
Chemotherapy plus radiotherapy and/or surgery 0.41 0.25–0.69
Radiotherapy/radiotherapy plus surgery 0.63 0.39–1.0
95% CI¼95% confidence interval.
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Figure 2 Plot of the work ability scores measured at 6 months in
relation to time to return-to-work, after adjustment for age and treatment
(n¼195).
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Figure 1 Mean value of current work ability at 6, 12 and 18 months after
the first day of sick leave for the three treatment combinations: surgery;
chemotherapy or chemotherapy plus radiotherapy and/or surgery; and
radiotherapy or radiotherapy plus surgery (n¼195).
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sIn our study, the mean current work ability scores at 6, 12 and
18 months after the first day of sick leave were 4.6, 6.3 and 6.7,
respectively. Although we found a significant improvement of
current work ability, these scores are lower than the average
current work ability score of 7.9 found by Pohjonen (2001) in a
sample of female home care workers in the age group 40–44 years
old with an average of two diagnosed benign diseases. It might be
possible that work ability scores in cancer patients will improve
still further 2 years after the diagnosis or that their work ability
scores might deteriorate because cancer has a larger impact on
work ability than other diseases.
Research on the effect of cancer diagnosis and treatment on
work ability is scarce; however, studies have shown recently that
most patients are employed but that both physical and mental
work ability can deteriorate owing to cancer (Gudbergsson
et al, 2006; Steinbach et al, 2006; Kennedy et al, 2007; Taskila
et al, 2007). Patients in the recent study of Kennedy et al (2007),
who were 1–10 years after diagnosis, reported that they had
difficulties in coping and concentrating, and they worried
about their reduced capability. In the comparative study of
Gudbergsson et al (2006), it was found that cancer patients
2–6 years after diagnosis, who had returned to work after
curative treatment, reported significantly poorer physical and
mental work capacity compared to employed matched controls
from the general population. Most survivors of glioblastoma in the
study of Steinbach et al (2006) also thought that their work
ability was impaired. According to Taskila et al (2007), 26% of
cancer survivors reported that their physical work ability
had deteriorated and 19% that their mental work ability had
deteriorated owing to cancer diagnosis and treatment. However,
the work ability as measured with the WAI of these
cancer survivors did not differ from that of a group of healthy
referent persons. This is probably also caused by the fact that all
their survivors with breast cancer, lymphoma and prostate cancer
had already returned to work and that they were long-term
survivors who had been diagnosed with cancer 2–6 years before
the time of the questionnaire. This could also explain the
differences in mean work ability scores between their study and
the patients in our study. For men in their study, the work ability
scores were 8.0 (for prostate cancer) to 8.9 (for testicular cancer)
compared to 6.9 for the men in our study 18 months after the first
day of sick leave. Our female patients scored 6.7 at the end of
follow-up compared to 8.2 (for breast cancer) and 8.5 (for
lymphoma) in the Finnish study by Taskila et al (2007). Our
study also showed that men initially showed higher scores of work
ability, while women improved faster and no differences were
found after 1 year. It might be possible that women, who were
mainly diagnosed with breast cancer, received more chemother-
apy, which would have prolonged the treatment period. Another
explanation might be that women could have more household
activities than men and that they take these into account when
judging their work ability.
Our study indicated work ability as an independent predictor for
return-to-work, while quality of life was only found to be
predictive of time until return-to-work in the univariate analyses.
The same result was found earlier for Norwegian patients with
back disorders who had been certified as sick (Reiso et al, 2003).
The authors of that study suggested that work ability questions
may be related more to function in a setting of sickness
certification than a global quality of life question and therefore
be more predictive.
In an earlier analysis (Spelten et al, 2003), we found that fatigue
at 6 months predicted a longer sick leave with an HR of 0.71,
adjusted for diagnosis, treatment, age and gender. Our present
study indicated that fatigue was only a predictive factor of return-
to-work in the univariate analyses but not in the multivariate
analyses, which included work ability. Because work ability and
fatigue were correlated, only work ability remained in the model as
the better predictor of return-to-work. Other studies have also
found that fatigue influenced conditions of employment and
productiveness (Hofman et al, 2007). Results of the univariate
analyses without the 46 patients who had already returned to work
at 6 months showed that gender was not a significant factor
anymore. This might be caused by the fact that most of these
returned patients were men (65%) and were diagnosed with testes
or prostate cancer (48%). In the model of best predictors of return-
to-work without those patients who had returned early, the factors
mental work ability and cognitive dysfunction were included. This
could imply that for patients who do not return early, the mental
and psychological factors become more dominant in relation to
return-to-work.
Leventhal’s ‘model of illness representations’ states that people’s
cognitive representations of illness play an important role in
influencing their strategies for coping, which in turn influence
illness outcomes (Leventhal et al, 1984). On the basis of this
model, the functional outcome might be worse or better,
irrespective of the objective medical seriousness of the illness.
Our results are congruent with this model. Irrespective of age,
diagnosis, treatment, quality of life, fatigue, and physical or
psychological complaints, self-assessed work ability strongly
predicted future return-to-work. This indicates that the ideas a
cancer patient has about his or her work disabilities that result
from the diagnosis and treatment of cancer are a reflection of the
true work capabilities. Therefore, the self-reported work ability
could be important in encouraging or hindering his or her return-
to-work.
Employment outcomes can be improved with innovations
in treatment and with clinical and supportive services aimed at
better management of symptoms, rehabilitation and accommoda-
tion of disabilities (Steiner et al, 2004). A recent study of
Bouknight et al (2006) showed that a high percentage of employed
breast cancer patients returned to work after treatment and
that workplace accommodations played an important role in their
return. Therefore, interventions should be developed to enable
cancer survivors to return to work or to succeed in
other appropriate employment, because no such interventions
aimed at work do exist at the present. These interventions
should aim especially at patients who indicate that their work
ability is diminished, at older patients and at those treated with
chemotherapy, since they are at the greatest risk of prolonged
work absence. Clinicians could play an important role in detecting
those patients at risk because our study has shown that the
indication of patients with possible return-to-work problems can
be assessed very early in the treatment process when they have
diminished self-reported work ability. Physicians could help
patients in the return-to-work process and therefore help in
improving their quality of life by asking patients if they have
returned to work or are experiencing problems in the return-to-
work process. If so, referral to occupational specialists could be
considered.
In conclusion, the work ability of cancer patients who work at
the time of their diagnosis is severely impaired in the first months
after the first day of sick leave, but it does improve significantly in
the months afterwards. Self-assessed work ability 6 months after
the first day of sick leave proved to be a strong predictor of later
return-to-work in cancer survivors independent of age and
therapy.
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